Pre- and post-translational regulation of osteopontin in cancer

被引：0

作者：

Pieter H. Anborgh

Jennifer C. Mutrie

Alan B. Tuck

Ann F. Chambers

机构：

[1] London Regional Cancer Program,Department of Pathology

[2] University of Western Ontario,Department of Oncology

[3] London Health Sciences Centre,undefined

[4] University of Western Ontario,undefined

来源：

Journal of Cell Communication and Signaling | 2011年 / 5卷

关键词：

Osteopontin; Cancer; Metastasis; Matricellular protein; Post-translational modification; Alternative splicing;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Osteopontin (OPN) is a matricellular protein that binds to a number of cell surface receptors including integrins and CD44. It is expressed in many tissues and secreted into body fluids including blood, milk and urine. OPN plays important physiological roles in bone remodeling, immune response and inflammation. It is also a tumour-associated protein, and elevated OPN levels are associated with tumour formation, progression and metastasis. Research has revealed a promising role for OPN as a cancer biomarker. OPN is subject to alternative splicing, as well as post-translational modifications such as phosphorylation, glycosylation and proteolytic cleavage. Functional differences have been revealed for different isoforms and post-translational modifications. The pattern of isoform expression and post-translational modification is cell-type specific and may influence the potential role of OPN in malignancy and as a cancer biomarker.

引用

页码：111 / 122

页数：11

共 737 条

[1]

Agnihotri R(2001)Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin) J Biol Chem 276 28261-28267

[2]

Crawford HC(2002)Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J Natl Cancer Inst 94 513-521

[3]

Haro H(2006)Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer Am J Pathol 169 233-246

[4]

Matrisian LM(2005)Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway J Cell Biochem 94 1218-1233

[5]

Havrda MC(2009)New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs Clin Chem 55 895-903

[6]

Liaw L(2010)Role of the metastasis-promoting protein osteopontin in the tumor microenvironment J Cell Mol Med 14 2037-2044

[7]

Agrawal D(2010)Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients BMC Cancer 10 132-381

[8]

Chen T(2007)Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers J Biomed Sci 14 373-1593

[9]

Irby R(2009)Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity J Thorac Cardiovasc Surg 139 1587-941

[10]

Quackenbush J(2010)Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer J Clin Oncol 28 936-1341

← 1 2 3 4 5 6 7 8 9 10 →